Adherex Technologies Financial Statements
Adherex Technologies Financial Information
| Company Type | Public Single Location |
|---|---|
| Fiscal Year-End | December |
| Annual Report | Company Web Site |
| Investor Relations | Company Web Site |
This data is provided as per license from EDGAR Online
Adherex Technologies Income Statement
| 2007 | 2006 | 2005 | |
|---|---|---|---|
| Revenue ($ mil.) | 0.0 | 0.0 | 0.0 |
| Gross Profit ($ mil.) | -- | -- | -- |
| Operating Income ($ mil.) | (14.2) | (14.9) | (16.9) |
| Total Net Income ($ mil.) | (13.4) | (16.4) | (13.9) |
| Diluted EPS (Net Income) | (0.11) | (0.34) | (0.35) |
Adherex Technologies Quarterly Statements
| Quarter Ending Mar 08 | Quarter Ending Dec 07 | Quarter Ending Sep 07 | |
|---|---|---|---|
| Revenue ($ mil.) | 0.0 | 0.0 | 0.0 |
| Gross Profit ($ mil.) | -- | -- | -- |
| Operating Income ($ mil.) | (4.4) | (3.2) | (3.5) |
| Total Net Income ($ mil.) | (4.3) | (3.0) | (3.2) |
| Diluted EPS (Net Income) | (0.03) | (0.02) | (0.02) |
Adherex Technologies Financial Ratios
| Company | Industry Median |
Market Median1 |
|
|---|---|---|---|
| Price/Sales Ratio | -- | 3.81 | 1.53 |
| Price/Earnings Ratio | -- | 16.07 | 15.12 |
| Price/Book Ratio | 2.18 | 2.80 | 1.46 |
| Price/Cash Flow Ratio | -- | 11.72 | 9.52 |
1 Public companies trading on the New York Stock Exchange, the American Stock Exchange, and the NASDAQ National Market.
Detailed Adherex Technologies Financial Ratios
Adherex Technologies Competitive Intelligence
| AstraZeneca | OXiGENE | Roche | |
|---|---|---|---|
| Annual Sales ($ mil.) | 29,559.0 | 0.0 | 34,465.2 |
| Employees | -- | -- | 74,372 |
| Market Cap ($ mil.) | -- | 32.8 | -- |
Competitive Landscape
